Fosun International LTD Acelrx Pharmaceuticals Inc Transaction History

Fosun International LTD

  • $106 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 10, 2019
SELL
$2.35 - $3.83 $709,013 - $1.16 Million
-301,708 Closed
0 $0
Q4 2018

Jan 31, 2019
SELL
$2.13 - $4.8 $377,734 - $851,232
-177,340 Reduced 37.02%
301,708 $709,000
Q3 2018

Nov 09, 2018
BUY
$2.6 - $4.6 $1.25 Million - $2.2 Million
479,048 New
479,048 $1.94 Million

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email